Zoekresultaten - 3 results
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
women diagnosed with histologically confirmed cervical intraepithelial neoplasia two or more (≥ CIN2, N=119) and controls defined as women with two subsequent negative cytology results (N=834). RESULTS: ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample adequacy, DNA extraction ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
under-screened women. METHODS: A systematic review and meta-analysis on randomised controlled trials (RCT s) were performed to update the evidence on the efficacy of strategies for offering self-sampling kits for HPV ...